◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Shree Cement Limited (SHREECEM) Revenue 2023–2026

Name: Shree Cement Limited (SHREECEM) revenue history 2023-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-20

Shree Cement Limited annual revenue for fiscal 2026 was ₹205.9 billion, an increase of 8.5% from ₹189.8 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

SHREECEM Annual Revenue

Revenue (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹205.9B	₹189.8B	₹200.9B	₹174.4B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SHREECEM Quarterly Revenue

Revenue (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31
Total Revenue	₹62.3B	₹61.0B	₹48.0B	₹52.8B	₹55.3B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

ULTRACEMCO Revenue — UltraTech Cement Limited
GRASIM Revenue — Grasim Industries Limited
AMBUJACEM Revenue — Ambuja Cements Limited
5233 Revenue — Taiheiyo Cement Corporation
JKCEMENT Revenue — J.K. Cement Limited
DALBHARAT Revenue — Dalmia Bharat Limited

More SHREECEM metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow

All SHREECEM financial statements → Interactive SHREECEM charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.